Stock MXCN MAXCYTE, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News MaxCyte, Inc. London S.E.

Equities

MXCN

USU575801258

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
MaxCyte, Inc. - Change of Name of Nominated Adviser and Broker
AQ
MaxCyte to Report Second Quarter 2024 Financial Results on August 6, 2024
GL
MaxCyte, Inc.(NasdaqGS:MXCT) dropped from Russell 3000E Growth Index
CI
MaxCyte, Inc.(NasdaqGS:MXCT) dropped from Russell 2000 Growth Index
CI
MaxCyte, Inc.(NasdaqGS:MXCT) dropped from Russell 3000 Growth Index
CI
MaxCyte, Inc.(NasdaqGS:MXCT) dropped from Russell Small Cap Comp Growth Index
CI
MaxCyte, Inc.(NasdaqGS:MXCT) dropped from Russell Microcap Growth Index
CI
MaxCyte, Inc.(NasdaqGS:MXCT) dropped from Russell 2500 Growth Index
CI
MaxCyte, Inc. - Publication of Annual Report
AQ
Porton Advanced introduces the MaxCyte ExPERT GTx Flow Electroporation instrument, continuing to provide customers with end-to-end cell and gene therapy CRO and CDMO services
AQ
MaxCyte, Inc. - Grant of Options and Restricted Stock Units
AQ
MaxCyte, Inc. - Results of AGM
AQ
MaxCyte, Inc. - PDMR Dealing
AQ
MaxCyte CEO Maher Masoud buys 100,000 shares
AN
Maxcyte Insider Bought Shares Worth $489,066, According to a Recent SEC Filing
MT
MaxCyte : Participation in Upcoming Investor Conference
PU
MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference
GL
MaxCyte inks deal with Legend Biotech for tech supply
AN
MaxCyte Signs License Deal With Legend Biotech for Cell Therapy Program
MT
MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MXCT Stock
  4. MXCN Stock
  5. News MaxCyte, Inc.